Arcutis Biotherapeutics, Inc. ARQT Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s interest paid?
- Arcutis Biotherapeutics, Inc. (ARQT) reported interest paid of $2.91M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s interest paid changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s interest paid increased by 13.2% year-over-year, from $2.57M to $2.91M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s interest paid has grown at a 192.0% compound annual growth rate (CAGR), from $142K to $10.33M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.